Oct 31, 2019 - Virginia's attorney general filed a new lawsuit Thursday over the opioid crisis, even as the top government lawyers in some states are pushing to settle claims over powerful prescription painkillers.
Oct 31, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.15 in the latest trading session, marking a -0.49% move from the prior day.
Nov 04, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to have hurt Teva's (TEVA) Q3 sales
Nov 05, 2019 - Mylan's (MYL) earnings beat estimates but sales miss the same in the third quarter of 2019. The company updates guidance for 2019.
Nov 07, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. Shares rise in pre-market trading.
Nov 07, 2019 - Investors grew optimistic that the company's legal and financial risks from the ongoing opioid epidemic may be coming to an end.
Nov 07, 2019 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2019 Results Conference Call November 07, 2019 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President of Investor Relations Kare Sc
Nov 08, 2019 - P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.